QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | |
( | ||
(Address of principal executive office) (Zip Code) | (Registrant’s telephone number, including area code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered |
N/A | N/A | N/A |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Part I. | Financial Information | |
Item 1. | Unaudited Consolidated Financial Statements | |
from February 11, 2025 (Inception) through March 31, 2025 ......................................................................... | ||
period from February 11, 2025 (Inception) through March 31, 2025 .............................................................. | ||
February 11, 2025 (Inception) through March 31, 2025 ................................................................................. | ||
Notes to Consolidated Financial Statements .................................................................................................... | ||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations .......................... | |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk ......................................................................... | |
Item 4. | Controls and Procedures ................................................................................................................................... | |
Part II. | Other Information | |
Item 1. | Legal Proceedings ............................................................................................................................................ | |
Item 1A. | Risk Factors ...................................................................................................................................................... | |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds ......................................................................... | |
Item 3. | Defaults Upon Senior Securities ...................................................................................................................... | |
Item 4. | Mine Safety Disclosures ................................................................................................................................... | |
Item 5. | Other Information ............................................................................................................................................. | |
Item 6. | Exhibits ............................................................................................................................................................. | |
Signatures ......................................................................................................................................................... |
March 31, 2026 | December 31, 2025 | ||
Assets | (unaudited) | ||
Investments, at fair value (cost of $ | $ | $ | |
Derivative assets, at fair value | |||
Cash and cash equivalents | |||
Interest and other income receivable | |||
Deferred offering costs | |||
Receivable from investments | |||
Total assets | $ | $ | |
Liabilities | |||
Payable for investments purchased | $ | $ | |
Derivative liabilities, at fair value | |||
Management fee payable | |||
Incentive allocation payable | |||
Due to affiliate | |||
Servicing fees payable | |||
Offering costs payable | |||
Accrued organizational expenses | |||
Other accrued expenses and liabilities | |||
Total liabilities | |||
Commitments and contingencies | |||
Net Assets | |||
Class A units, unlimited units authorized, | |||
Class S units, unlimited units authorized, | |||
Class D units, unlimited units authorized, | |||
Class I units, unlimited units authorized, | |||
Class A-A units, unlimited units authorized, | |||
Class A-S units, unlimited units authorized, of March 31, 2026 and December 31, 2025, respectively | |||
Class A-D units, unlimited units authorized, | |||
Class A-I units, unlimited units authorized, as of March 31, 2026 and December 31, 2025, respectively | |||
Class E-A units, unlimited units authorized, March 31, 2026 and December 31, 2025, respectively | |||
Class E-S units, unlimited units authorized, of March 31, 2026 and December 31, 2025, respectively | |||
Class E-D units, unlimited units authorized, | |||
Class E-I units, unlimited units authorized, as of March 31, 2026 and December 31, 2025, respectively | |||
Class C units, unlimited units authorized, of March 31, 2026 and December 31, 2025, respectively | |||
Class CG units, unlimited units authorized, | |||
Total net assets | |||
Total liabilities and net assets | $ | $ |
Three Months Ended March 31, 2026 | For the Period from February 11, 2025 (Inception) through March 31, 2025 | ||
Investment income: | |||
Dividend income | $ | $ | |
Interest income | |||
Total investment income | |||
Expenses: | |||
Organizational expenses | |||
Offering cost expense | |||
Management fees | |||
Incentive allocation | |||
Professional fees | |||
Administrative fees | |||
Other expenses | |||
Total expenses | |||
Management fees waived | ( | ||
Total expenses after fees waived | |||
Net investment loss | ( | ||
Net realized gain and change in unrealized appreciation/(depreciation): | |||
Net realized gain on investments | |||
Net realized gain on derivative contracts | |||
Net change in unrealized appreciation on investments | |||
Net change in unrealized depreciation on derivative contracts | ( | ||
Net realized and unrealized gain on investments, including derivative contracts | |||
Net increase in net assets resulting from operations | $ | $ | |
Class A-S Units | Class A-I Units | Class E-A Units | Class E-S Units | Class E-I Units | Class C Units | Total Net Assets | |||||||
Net Assets at February 11, 2025 (Inception) | $ | $ | $ | $ | $ | $ | $ | ||||||
Proceeds from units issued | |||||||||||||
Net Assets at March 31, 2025 | $ | $ | $ | $ | $ | $ | $ |
Class A-S Units | Class A-I Units | Class E-A Units | Class E-S Units | Class E-I Units | Class C Units | Total Net Assets | |||||||
Net Assets at December 31, 2025 | $ | $ | $ | $ | $ | $ | $ | ||||||
Proceeds from units issued | |||||||||||||
Net investment loss | ( | ( | ( | ( | ( | ( | ( | ||||||
Net realized gain on investments | |||||||||||||
Net realized gain on derivative contracts | ( | ||||||||||||
Net change in unrealized appreciation on investments | |||||||||||||
Net change in unrealized appreciation on derivative contracts | ( | ( | ( | ( | ( | ( | |||||||
Servicing fees | ( | ( | ( | ( | |||||||||
Distributions for units redeemed | ( | ( | |||||||||||
Net Assets at March 31, 2026 | $ | $ | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2026 | For the Period from February 11, 2025 (Inception) through March 31, 2025 | ||
Cash flows from operating activities: | |||
Net increase in net assets resulting from operations | $ | $ | |
Adjustments to reconcile net increase in net assets resulting from operations to net cash used in operating activities: | |||
Net realized gain on investments | ( | ||
Net realized gain on derivative contracts | ( | ||
Net change in unrealized appreciation on investments | ( | ||
Net change in unrealized depreciation on derivative contracts | |||
Cost of investments purchased | ( | ||
Proceeds from sales and repayments of investments | |||
Proceeds from settlement of derivative contracts | |||
Changes in operating assets: | |||
Interest and other income receivable | |||
Deferred offering costs | |||
Receivable from investment | ( | ||
Changes in operating liabilities: | |||
Payable for investments purchased | ( | ||
Management fee payable | |||
Incentive allocation payable | |||
Offering costs payable | |||
Due to affiliate | |||
Accrued expenses and other liabilities | |||
Net cash used in operating activities | ( | ||
Cash flows from financing activities: | |||
Proceeds from issuance of units | |||
Redemption of units | ( | ||
Servicing fees paid | ( | ||
Net cash provided by financing activities | |||
Net increase in cash and cash equivalents | |||
Cash and cash equivalents, beginning of period | |||
Cash and cash equivalents, end of period | $ | $ | |
Supplemental disclosures of non-cash information | |||
Servicing fee payable | $ | $ |
Issuer | Asset | Geography (3) | Fair Value ($) (2) | Fair Value as Percentage of Net Assets (%) | ||||
Investments in Portfolio Companies | ||||||||
Aerospace & Defense | ||||||||
Other Investments in Portfolio Companies (1) | Americas | $ | ||||||
Consumer Services | ||||||||
Other Investments in Portfolio Companies (1) | Japan | |||||||
Financial Services | ||||||||
Other Investments in Portfolio Companies (1) | Americas | |||||||
Total Financial Services | ||||||||
Healthcare | ||||||||
Knack RCM | Equity interest held through CA Poppy Holdings | Other Asia | ||||||
Tarrytown Expocare Pharmacy | Equity interests held through CP Maverick Holdings, L.P. and CP Catapult Holdings, L.P. | Americas | ||||||
Vantive | Equity interest held through CP VIII Participations S.a.r.l., SICAR | Americas | ||||||
Other Investments in Portfolio Companies (1) | Japan | |||||||
Total Healthcare | ||||||||
Industrials | ||||||||
Waste Services Group Pty Ltd | Equity interest held through CAP V Odin, L.P. | Australia | ||||||
TRYT, Inc. | Equity interest held through CJP V HC Holdings VI, L.P. | Japan | ||||||
Other Investments in Portfolio Companies (1) | Europe | |||||||
Other Investments in Portfolio Companies (1) | Americas | |||||||
Other Investments in Portfolio Companies (1) | Other Asia | |||||||
Total Industrials | ||||||||
Issuer | Asset | Geography (3) | Fair Value ($) (2) | Fair Value as Percentage of Net Assets (%) | ||||
Technologies | ||||||||
Kyoden Co., Ltd | Equity interest held through Fountain Holdings, L.P. | Japan | $ | |||||
Other Investments in Portfolio Companies (1) | Americas | |||||||
Other Investments in Portfolio Companies (1) | Japan | |||||||
Other Investments in Portfolio Companies (1) | Europe | |||||||
Total Technologies | ||||||||
Total Investments in Portfolio Companies | ||||||||
(Cost: $ | ||||||||
Investments in Affiliated Investee Funds | ||||||||
Aerospace & Defense | ||||||||
Other Investments in affiliated investee funds (1) | Americas | |||||||
Financial Services | ||||||||
Other Investments in affiliated investee funds (1) | Americas | |||||||
Healthcare | ||||||||
Other Investments in affiliated investee funds (1) | Americas | |||||||
Industrials | ||||||||
Other Investments in affiliated investee funds (1) | Europe | |||||||
Total Investments in Affiliated Investee Funds | ||||||||
(Cost: $ | ||||||||
Investments in Unaffiliated Investee Funds | ||||||||
Industrials | ||||||||
Other Investments in Secondaries (1) | Americas | |||||||
Issuer | Asset | Geography (3) | Fair Value ($) (2) | Fair Value as Percentage of Net Assets (%) | ||||
Various | ||||||||
Other Investments in Secondaries (1) | Americas | $ | ||||||
Total Investments in Unaffiliated Investee Funds | ||||||||
(Cost: $ | ||||||||
Total Investments | $ | |||||||
Derivative Instruments | ||||||||
Foreign Currency Forward Contracts (assets) | $ | |||||||
Foreign Currency Forward Contracts (liabilities) | ( | ( | ||||||
Total Derivative Instruments | $ | |||||||
(Cost: $ | ||||||||
Cash Equivalents | ||||||||
Morgan Stanley Institutional Liquidity Funds - Government Portfolio (Institutional Class) | Americas | $ | ||||||
Total Cash Equivalents | $ | |||||||
(Cost: $ | ||||||||
Total Investments, Derivative Instruments and Cash Equivalents | $ | |||||||
(Cost: $ | ||||||||
Issuer | Asset | Geography (4) | Fair Value ($) (2) | Fair Value as Percentage of Net Assets (%) | ||||
Investments in Portfolio Companies | ||||||||
Aerospace & Defense | ||||||||
Other Investments in Portfolio Companies (1) | Americas | $ | ||||||
Consumer Services | ||||||||
Other Investments in Portfolio Companies (1) | Japan | |||||||
Financial Services | ||||||||
Other Investments in Portfolio Companies (1) | Americas | |||||||
Total Financial Services | ||||||||
Healthcare | ||||||||
Knack RCM | Equity interest held through CA Poppy Holdings | Other Asia | ||||||
Tarrytown Expocare Pharmacy | Equity interests held through CP Maverick Holdings, L.P. and CP Catapult Holdings, L.P. | Americas | ||||||
Other Investments in Portfolio Companies (1) | Americas | |||||||
Total Healthcare | ||||||||
Industrials | ||||||||
Waste Services Group Pty Ltd | Equity interest held through CAP V Odin, L.P. | Australia | ||||||
TRYT, Inc. | Equity interest held through CJP V HC Holdings VI, L.P. | Japan | ||||||
Other Investments in Portfolio Companies (1) | Europe | |||||||
Other Investments in Portfolio Companies (1) | Americas | |||||||
Total Industrials | ||||||||
Issuer | Asset | Geography (4) | Fair Value ($) (2) | Fair Value as Percentage of Net Assets (%) | ||||
Technologies | ||||||||
Adastra | Equity interest held through CETP V Participations S.a.r.l., SICAR | Europe | $ | |||||
Ingentis | Equity interest held through CETP V Participations S.a.r.l., SICAR | Europe | ||||||
Kyoden Co., Ltd | Equity interest held through Fountain Holdings, L.P. | Japan | ||||||
Other Investments in Portfolio Companies (1) | Americas | |||||||
Other Investments in Portfolio Companies (1) | Japan | |||||||
Other Investments in Portfolio Companies (1) | Europe | |||||||
Total Technologies | ||||||||
Total Investments in Portfolio Companies | ||||||||
(Cost: $ | ||||||||
Investments in Affiliated Investee Funds | ||||||||
Aerospace & Defense | ||||||||
Partnership interest in Carlyle Moose Coinvestment, L.P. (3) | Americas | |||||||
Total Aerospace & Defense | ||||||||
Financial Services | ||||||||
Other Investments in affiliated investee funds (1) | Americas | |||||||
Healthcare | ||||||||
Other Investments in affiliated investee funds (1) | Americas | |||||||
Total Healthcare | ||||||||
Total Investments in Affiliated Investee Funds | ||||||||
(Cost: $ | ||||||||
Issuer | Asset | Geography (4) | Fair Value ($) (2) | Fair Value as Percentage of Net Assets (%) | ||||
Investments in Unaffiliated Investee Funds | ||||||||
Industrials | ||||||||
Audax Private Equity Beacon CF | Equity interest through ASP Bluebird, L.P. | Americas | $ | |||||
Total Industrials | ||||||||
Various | ||||||||
Other Investments in Secondaries (1) | Americas | |||||||
Total Various | ||||||||
Total Investments in Unaffiliated Investee Funds | ||||||||
(Cost: $ | ||||||||
Total Investments | $ | |||||||
Derivative Instruments | ||||||||
Foreign Currency Forward Contracts (assets) | $ | |||||||
Foreign Currency Forward Contracts (liabilities) | ( | ( | ||||||
Total Derivative Instruments | $ | |||||||
(Cost: $ | ||||||||
Cash Equivalents | ||||||||
Morgan Stanley Institutional Liquidity Funds - Government Portfolio (Institutional Class) | Americas | $ | ||||||
Total Cash Equivalents | $ | |||||||
(Cost: $ | ||||||||
Total Investments, Derivative Instruments and Cash Equivalents | $ | |||||||
(Cost: $ | ||||||||
March 31, 2026 | |||||||||
Level I | Level II | Level III | NAV | Total | |||||
Assets | |||||||||
Cash and Cash Equivalents | |||||||||
Money Market Fund | $ | $ | $ | $ | $ | ||||
Total Cash and Cash Equivalents(1) | |||||||||
Investments | |||||||||
Investments in portfolio companies | |||||||||
Investments in affiliated and non- affiliated investee funds | |||||||||
Total Investments | |||||||||
Derivative Assets | |||||||||
Total | $ | $ | $ | $ | $ | ||||
Liabilities | |||||||||
Derivative Liabilities | $ | $ | $ | $ | $ | ||||
December 31, 2025 | |||||||||
Level I | Level II | Level III | NAV | Total | |||||
Assets | |||||||||
Cash and Cash Equivalents | |||||||||
Money Market Fund | $ | $ | $ | $ | $ | ||||
Total Cash and Cash Equivalents(1) | |||||||||
Investments | |||||||||
Investments in portfolio companies | |||||||||
Investments in affiliated and non- affiliated investee funds | |||||||||
Total Investments | |||||||||
Derivative Assets | |||||||||
Total | $ | $ | $ | $ | $ | ||||
Liabilities | |||||||||
Derivative Liabilities | $ | $ | $ | $ | $ | ||||
Fair Value as of March 31, 2026 | Valuation Techniques | Significant Unobservable Inputs | Range | Weighted Average | Impact to Valuation from Increase in Input | ||||||||
Low | High | ||||||||||||
Investments in portfolio companies | $ | Discounted Cash Flow | Discount Rate | Lower | |||||||||
Terminal Growth Rate | Higher | ||||||||||||
Comparable Multiple | EBITDA Multiple | Higher | |||||||||||
Revenue Multiple | Higher | ||||||||||||
Total Level III Investments | $ | ||||||||||||
Fair Value as of December 31, 2025 | Valuation Techniques | Significant Unobservable Inputs | Range | Weighted Average | Impact to Valuation from Increase in Input | ||||||||
Low | High | ||||||||||||
Investments in portfolio companies | $ | Discounted Cash Flow | Discount Rate | Lower | |||||||||
Terminal Growth Rate | Higher | ||||||||||||
Comparable Multiple | EBITDA Multiple | Higher | |||||||||||
Revenue Multiple | Higher | ||||||||||||
Total Level III Investments | $ | ||||||||||||
Equity Securities | ||
Balance, beginning of period | $ | |
Purchases | ||
Sales and proceeds from Investments | ( | |
Transfers into Level III | ||
Transfers out of Level III | ||
Net realized gains (losses) | ||
Net change in unrealized appreciation | ||
Balance, end of period | $ | |
Net change in unrealized appreciation included in earnings related to investments still held at the reporting date included in net change in unrealized appreciation on investments on the consolidated statement of operations | $ |
March 31, 2026 | December 31, 2025 | |||||||||||||||
Assets | Liabilities | Assets | Liabilities | |||||||||||||
Notional | Fair Value | Notional | Fair Value | Notional | Fair Value | Notional | Fair Value | |||||||||
Derivative Investments | ||||||||||||||||
Foreign Currency Forward Contracts (EUR) | € | $ | € | $( | € | $ | € | $( | ||||||||
Foreign Currency Forward Contracts (JPY) | ¥ | ¥ | ( | ¥ | ¥ | |||||||||||
Foreign Currency Forward Contracts (AUD) | A$ | A$ | ( | A$ | A$ | ( | ||||||||||
Foreign Currency Forward Contracts (INR) | Rs | Rs | ( | Rs | Rs | |||||||||||
Foreign Currency Forward Contracts (CAD) | C$ | C$ | C$ | C$ | ( | |||||||||||
$ | $( | $ | $( | |||||||||||||
Standard Units | Class A Units, Class S Units, Class D Units, Class I Units | |
Anchor Units (1) | Class A-A Units, Class A-S Units, Class A-D Units, Class A-I Units | |
Early Investor Units (2) | Class E-A Units, Class E-S Units, Class E-D Units, Class E-I Units |
Subscription Fee | Classes of Units | |
Class A Units, Class S Units, Class A-A Units, Class A-S Units, Class E-A Units, Class E-S Units | ||
Class D Units, Class A-D Units, Class E-D Units | ||
Class I Units, Class A-I Units, Class E-I Units, Class C Units, Class CG Units |
Class A-S Units | Class A-I Units | Class E-A Units | Class E-S Units | Class E-I Units | Class C Units | |||||||
Units Outstanding as of December 31, 2025 | ||||||||||||
Units issued | ||||||||||||
Non-cash redemptions (1) | ( | |||||||||||
Units Outstanding as of March 31, 2026 |
Class A-S Units | Class A-I Units | Class E-A Units | Class E-S Units | Class E-I Units | Class C Units | |||||||
Units Outstanding as of February 11, 2025 (Inception) | ||||||||||||
Units issued | ||||||||||||
Non-cash redemptions | ||||||||||||
Units Outstanding as of March 31, 2025 |
Servicing Fee (per annum) | Classes of Units (1) | |
Class S Units, Class A-S Units, Class E-S Units | ||
Class A Units, Class A-A Units, Class E-A Units | ||
Class D Units, Class A-D Units, Class E-D Units | ||
Class I Units, Class A-I Units, Class E-I Units, Class C Units, Class CG Units |
For the three months ended March 31, 2026 | ||||||||||||
Class A-S Units | Class A-I Units | Class E-S Units | Class E-I Units | Class E-A Units | Class C Units | |||||||
Class Inception Date | Oct 1, 2025 | Oct 1, 2025 | Dec 1, 2025 | Nov 3, 2025 | Mar 2, 2026 | Oct 1, 2025 | ||||||
Per Unit Data: | ||||||||||||
Net asset value per Unit, beginning of period | $ | $ | $ | $ | $ | $ | ||||||
Proceeds from Units issued (1) | ||||||||||||
Net investment loss (2) | ( | ( | ( | ( | ( | ( | ||||||
Net realized and unrealized gain on investments, including derivative contracts (2) | ||||||||||||
Servicing fees | ( | ( | ( | |||||||||
Net asset value per Unit, end of period | $ | $ | $ | $ | $ | $ | ||||||
Number of Units outstanding, end of period | ||||||||||||
Total return based on net asset value (3) | ( | |||||||||||
Ratio to Weighted-Average Net Assets(4): | ||||||||||||
Incentive Allocation | ( | ( | ( | ( | ( | |||||||
Total Expenses before waived expenses | ( | ( | ( | ( | ( | ( | ||||||
Total waived expenses | ||||||||||||
Total Expenses after waived expenses | ( | ( | ( | ( | ( | ( | ||||||
Net investment loss | ( | ( | ( | ( | ( | ( | ||||||

Company | Strategy | Geography | Sector | |||
Knack RCM | International Exposure | Other Asia | Healthcare | |||
Kyoden Co., Ltd. | International Exposure | Japan | Technology | |||
Mantech (1) | Scale | North America | Aerospace & Defense | |||
Sedgwick Inc. | Scale | North America | Financial Services | |||
Tarrytown Expocare Pharmacy | Scale | North America | Healthcare | |||
Trucordia | Opportunistic | North America | Financial Services | |||
TRYT Inc. | International Exposure | Japan | Industrials | |||
Vantive | Scale | North America | Healthcare | |||
Waste Services Group Pty Ltd | International Exposure | Australia | Industrials | |||
Worldpac | Scale | North America | Industrials |
Unit Class | Class Inception Date | Year To Date Total Return (2) | Inception To Date Total Return (1) | |||
Class A-I | Oct 1, 2025 | 4.74% | 15.93% | |||
Class E-I | Nov 3, 2025 | 4.56% | 11.19% | |||
Class A-S | Oct 1, 2025 | 4.53% | 15.61% | |||
Class E-S | Dec 1, 2025 | 4.42% | 6.38% | |||
Class E-A | Mar 2, 2026 | 1.76% | 1.76% | |||
Class C (3) | Oct 1, 2025 | 5.41% | 18.36% |
Components of CPEP’s Transactional NAV | Consolidated NAV | |
Investments, at fair value | $73,576 | |
Derivative assets, at fair value | 493 | |
Cash and cash equivalents | 14,219 | |
Other assets | 285 | |
Derivative liabilities, at fair value | (265) | |
Accrued incentive allocation | (444) | |
Other liabilities | (103) | |
Management fee payable | (36) | |
Transactional NAV | $87,725 |
As of March 31, 2026 | ||||||
Class | Number of Units | Transactional NAV per Unit(1) | Transactional NAV ($ in thousands) | |||
Class A-I | 868,820 | $28.98 | $25,180 | |||
Class A-S | 29,000 | 28.90 | 838 | |||
Class E-I | 1,923,732 | 28.91 | 55,615 | |||
Class E-S | 11,050 | 28.88 | 319 | |||
Class E-A | 48,143 | 28.90 | 1,391 | |||
Class C | 148,072 | 29.59 | 4,382 | |||
3,028,817 | $87,725 | |||||
March 31, 2026 | ||
U.S. GAAP Net Asset Value | $81,952 | |
Adjustments | ||
Organizational, offering, and other Fund expenses (1) | 5,642 | |
Servicing Fees (2) | 131 | |
Transactional NAV | $87,725 |
Exhibit No. | Description | |
3.1 | ||
3.2 | ||
31.1 | ||
31.2 | ||
32.1 | ||
32.2 | ||
101.INS | Inline XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
104 | Cover Page Interactive Data (included within the Exhibit 101 attachments). | |
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P. | |||
Dated: May 14, 2026 | By: | /s/ Charles E. Andrews, Jr. | |
Charles E. Andrews, Jr. | |||
Chief Financial Officer | |||
(Principal Financial Officer and Principal Accounting Officer) | |||